{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:09:33Z","timestamp":1784038173095,"version":"3.55.0"},"reference-count":42,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Monoclonal gammopathy of undetermined significance (MGUS) is a necessary precursor of multiple myeloma (MM). Compared with non-Hispanic White (White) patients, African American individuals experience approximately twofold greater, and Asian American individuals 50% lower, occurrence of MGUS and MM. We examined determinants of MGUS among Japanese American, African American, Latino, Native Hawaiian, and White participants in a case-control study nested in the Multiethnic Cohort (MEC) study. Presumptive cases included MEC participants aged \u226565 years initially screened using the Medicare billing code for paraproteinemia along with those diagnosed with MM or another plasma cell neoplasm at least 1 year after blood draw. Presumptive controls had no Medicare paraproteinemia billing code or MM. Laboratory confirmation resulted in 426 confirmed MGUS cases (370 non-immunoglobulin M [non-IgM] and 56 IgM) and 863 MGUS-free controls. We used multivariable logistic regression to estimate associations with MGUS. The distribution of immunoglobulin isotypes differed by race\/ethnicity (P = .005): Japanese American individuals had the lowest (11.0%) and Native Hawaiian individuals the highest (23.5%) proportion of IgA. Each unit increase in body mass index (BMI; kilogram per square meter) was associated with a 6% increase in non-IgM MGUS (95% confidence interval, 3-9) among all racial\/ethnic groups combined. BMI was also significantly associated within most racial\/ethnic groups, especially among Native Hawaiian individuals (13% increase per BMI unit), with IgA and IgG MGUS, and with high and low risk MGUS. BMI was the main determinant associated with MGUS. Isotype distribution differed between racial\/ethnic groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015266","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:55:36Z","timestamp":1768337736000},"page":"4551-4562","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["A nested case-control study of monoclonal gammopathy of undetermined significance in the Multiethnic Cohort study"],"prefix":"10.1182","volume":"10","author":[{"given":"Maryam","family":"Salehi","sequence":"first","affiliation":[{"name":"1Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Wilkens","sequence":"additional","affiliation":[{"name":"2Epidemiology Program, University of Hawai\u2018i Cancer Center, Honolulu, HI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Yin","family":"Wan","sequence":"additional","affiliation":[{"name":"3Department of Epidemiology and Biostatistics, UCI Program in Public Health, The Susan & Henry Samueli College of Health Sciences, University of California, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria K.","family":"Cortessis","sequence":"additional","affiliation":[{"name":"4Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7099-9022","authenticated-orcid":false,"given":"Daniel O.","family":"Stram","sequence":"additional","affiliation":[{"name":"4Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Conti","sequence":"additional","affiliation":[{"name":"4Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA"},{"name":"5Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9275-1893","authenticated-orcid":false,"given":"Jose A.","family":"Aparicio","sequence":"additional","affiliation":[{"name":"5Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4418-7229","authenticated-orcid":false,"given":"Esther","family":"Lam","sequence":"additional","affiliation":[{"name":"1Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7498-2391","authenticated-orcid":false,"given":"Mallory P.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"1Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinkal","family":"Desai","sequence":"additional","affiliation":[{"name":"6Division of Hematology\/Oncology, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4565-7618","authenticated-orcid":false,"given":"Kimberly A.","family":"Bertrand","sequence":"additional","affiliation":[{"name":"7Slone Epidemiology Center at Boston University, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0714-734X","authenticated-orcid":false,"given":"Aaron Seth","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"8Department of Medicine, University of California Davis School of Medicine, University of California Davis, Sacramento, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lee","sequence":"additional","affiliation":[{"name":"1Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Le Marchand","sequence":"additional","affiliation":[{"name":"2Epidemiology Program, University of Hawai\u2018i Cancer Center, Honolulu, HI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Haiman","sequence":"additional","affiliation":[{"name":"4Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA"},{"name":"5Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Emerson","sequence":"additional","affiliation":[{"name":"9Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3415-8247","authenticated-orcid":false,"given":"Wendy","family":"Cozen","sequence":"additional","affiliation":[{"name":"1Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California, Irvine, CA"},{"name":"3Department of Epidemiology and Biostatistics, UCI Program in Public Health, The Susan & Henry Samueli College of Health Sciences, University of California, Irvine, CA"},{"name":"10Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA"},{"name":"11Department of Pathology, School of Medicine, University of California, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"12","key":"2026071409572757700_bib1","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"2026071409572757700_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"2026071409572757700_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"Br J Haematol"},{"issue":"13","key":"2026071409572757700_bib4","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"2026071409572757700_bib5","first-page":"931","article-title":"Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States)","volume":"17","author":"Gebregziabher","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"12","key":"2026071409572757700_bib6","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","article-title":"Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana","volume":"82","author":"Landgren","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2026071409572757700_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2026071409572757700_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-020-0284-7","article-title":"Dissecting racial disparities in multiple myeloma","volume":"10","author":"Marinac","year":"2020","journal-title":"Blood Cancer J"},{"issue":"10","key":"2026071409572757700_bib9","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1038\/bcj.2017.97","article-title":"Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey","volume":"7","author":"Landgren","year":"2017","journal-title":"Blood Cancer J"},{"issue":"7","key":"2026071409572757700_bib10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"2026071409572757700_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hon.2548","article-title":"Monoclonal gammopathy of undetermined significance in Chinese population: a prospective epidemiological study","volume":"37","author":"Ma","year":"2019","journal-title":"Hematol Oncol"},{"issue":"10","key":"2026071409572757700_bib12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4065\/mcp.2010.0337","article-title":"Prevalence of monoclonal gammopathy of undetermined significance: a systematic review","volume":"85","author":"Wadhera","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"2026071409572757700_bib13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","article-title":"Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women","volume":"116","author":"Landgren","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2026071409572757700_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","article-title":"Risk of plasma cell and lymphoproliferative disorders among 14 621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden","volume":"114","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2026071409572757700_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00277-021-04400-7","article-title":"Risk factors for monoclonal gammopathy of undetermined significance: a systematic review","volume":"100","author":"Castaneda-Avila","year":"2021","journal-title":"Ann Hematol"},{"issue":"8","key":"2026071409572757700_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"2026071409572757700_bib17","doi-asserted-by":"crossref","first-page":"djw264","DOI":"10.1093\/jnci\/djw264","article-title":"Obesity and the transformation of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based cohort study","volume":"109","author":"Chang","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"2026071409572757700_bib18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/jnci\/djp175","article-title":"Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group","volume":"101","author":"Albain","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2026071409572757700_bib19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2026071409572757700_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"10","key":"2026071409572757700_bib21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4065\/mcp.2010.0520","article-title":"Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence","volume":"85","author":"Rajkumar","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"2026071409572757700_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41408-022-00659-9","article-title":"Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota","volume":"12","author":"Kleinstern","year":"2022","journal-title":"Blood Cancer J"},{"issue":"4","key":"2026071409572757700_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/oxfordjournals.aje.a010213","article-title":"A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics","volume":"151","author":"Kolonel","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2026071409572757700_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"Kyle","year":"2003","journal-title":"Br J Haematol"},{"key":"2026071409572757700_bib25","unstructured":"WHO Consultation on Obesity (1997: Geneva, Switzerland), World Health Organization. Division of Noncommunicable Diseases & World Health Organization. Programme of Nutrition, Family and Reproductive Health\n          . Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation on Obesity. 1997. Accessed 28 January 2026. https:\/\/iris.who.int\/handle\/10665\/63854."},{"issue":"24","key":"2026071409572757700_bib26","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1002\/sim.2098","article-title":"Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study","volume":"23","author":"Thi\u00e9baut","year":"2004","journal-title":"Stat Med"},{"issue":"5","key":"2026071409572757700_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","article-title":"Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly","volume":"104","author":"Cohen","year":"1998","journal-title":"Am J Med"},{"issue":"6","key":"2026071409572757700_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ajh.22025","article-title":"Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients","volume":"86","author":"Weiss","year":"2011","journal-title":"Am J Hematol"},{"issue":"4","key":"2026071409572757700_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/leu.2011.368","article-title":"Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites","volume":"26","author":"Greenberg","year":"2012","journal-title":"Leuk"},{"issue":"9","key":"2026071409572757700_bib30","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.1002\/ajh.26638","article-title":"Prevalence of monoclonal gammopathy of undetermined significance in US black women","volume":"97","author":"Bertrand","year":"2022","journal-title":"Am J Hematol"},{"key":"2026071409572757700_bib31","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1038\/bcj.2015.8","article-title":"Racial differences in primary cytogenic abnormalities in multiple myeloma: a multi-center study","volume":"5","author":"Greenberg","year":"2015","journal-title":"Blood Cancer J"},{"key":"2026071409572757700_bib33","volume-title":"Hawai'i Cancer at a Glance 2014-2018","year":"2022"},{"issue":"25","key":"2026071409572757700_bib34","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1182\/blood-2012-03-417253","article-title":"Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium","volume":"120","author":"Birmann","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2026071409572757700_bib35","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/0008-5472.CAN-15-2406","article-title":"Low levels of circulating adiponectin are associated with multiple myeloma risk in overweight and obese individuals","volume":"76","author":"Hofmann","year":"2016","journal-title":"Cancer Res"},{"issue":"1","key":"2026071409572757700_bib36","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2352-3026(14)00037-4","article-title":"Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study","volume":"2","author":"Chang","year":"2015","journal-title":"Lancet Haematol"},{"issue":"5","key":"2026071409572757700_bib37","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/10428194.2016.1236375","article-title":"Impact of metformin on the progression of MGUS to multiple myeloma","volume":"58","author":"Boursi","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2026071409572757700_bib38","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2352-3026(14)00037-4","article-title":"Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study","volume":"2","author":"Chang","year":"2015","journal-title":"Lancet Haematol"},{"issue":"11","key":"2026071409572757700_bib39","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/s41375-019-0470-4","article-title":"Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells","volume":"33","author":"Mishra","year":"2019","journal-title":"Leukemia"},{"issue":"suppl 1","key":"2026071409572757700_bib40","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood-2021-151878","article-title":"A randomized placebo-controlled phase 2 study of metformin for the prevention of progression of monoclonal gammopathy of undetermined significance and low risk smoldering multiple myeloma","volume":"138","author":"Marinac","year":"2021","journal-title":"Blood"},{"issue":"4","key":"2026071409572757700_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41408-022-00642-4","article-title":"Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial","volume":"12","author":"Chang","year":"2022","journal-title":"Blood Cancer J"},{"issue":"4","key":"2026071409572757700_bib42","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1016\/j.clml.2024.12.006","article-title":"Associations between patient characteristics and progression to multiple myeloma among patients with monoclonal gammopathy of undetermined significance: a systematic review","volume":"25","author":"Li","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"2026071409572757700_bib43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jamaoncol.2025.1285","article-title":"New definition of light chain monoclonal gammopathy of undetermined significance","volume":"11","author":"Einarsson Long","year":"2025","journal-title":"JAMA Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4551\/2530397\/blooda_adv-2024-015266-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4551\/2530397\/blooda_adv-2024-015266-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:57:40Z","timestamp":1784037460000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/13\/4551\/565990\/A-nested-case-control-study-of-monoclonal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":42,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015266","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,14]]},"published":{"date-parts":[[2026,6,26]]}}}